Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals.

Tenover FC, Tickler I, Armstrong ES, Kubo A, Lopez S, Persing DH, Miller GH.

Int J Antimicrob Agents. 2011 Oct;38(4):352-4. doi: 10.1016/j.ijantimicag.2011.05.016. Epub 2011 Aug 5.

PMID:
21820877
2.

Characterisation of genes encoding aminoglycoside-modifying enzymes among meticillin-resistant Staphylococcus aureus isolated from two hospitals in Tehran, Iran.

Fatholahzadeh B, Emaneini M, Feizabadi MM, Sedaghat H, Aligholi M, Taherikalani M, Jabalameli F.

Int J Antimicrob Agents. 2009 Mar;33(3):264-5. doi: 10.1016/j.ijantimicag.2008.09.018. Epub 2008 Dec 11.

PMID:
19084382
3.
4.

The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, Heinz HP, Jones ME.

J Antimicrob Chemother. 1999 Feb;43(2):253-9.

PMID:
11252331
5.

Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.

Askarian M, Zeinalzadeh A, Japoni A, Alborzi A, Memish ZA.

Int J Infect Dis. 2009 Sep;13(5):e241-7. doi: 10.1016/j.ijid.2008.11.026. Epub 2009 Mar 9.

6.

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.

Zhanel GG, Lawson CD, Zelenitsky S, Findlay B, Schweizer F, Adam H, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA.

Expert Rev Anti Infect Ther. 2012 Apr;10(4):459-73. doi: 10.1586/eri.12.25. Review.

PMID:
22512755
7.

Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000.

Klingenberg C, Sundsfjord A, Rønnestad A, Mikalsen J, Gaustad P, Flaegstad T.

J Antimicrob Chemother. 2004 Nov;54(5):889-96. Epub 2004 Oct 7.

PMID:
15471996
8.

In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.

Vidaillac C, Leonard SN, Rybak MJ.

Int J Antimicrob Agents. 2010 Jun;35(6):527-30. doi: 10.1016/j.ijantimicag.2010.02.006. Epub 2010 Mar 26.

PMID:
20346632
9.

Resistance to gentamicin and related aminoglycosides in Staphylococcus aureus isolated in Brazil.

Freitas FI, Guedes-Stehling E, Siqueira-Júnior JP.

Lett Appl Microbiol. 1999 Sep;29(3):197-201.

10.

Methicillin and aminoglycoside resistance in Staphylococcus aureus isolates from bovine mastitis and sequence analysis of their mecA genes.

Turutoglu H, Hasoksuz M, Ozturk D, Yildirim M, Sagnak S.

Vet Res Commun. 2009 Dec;33(8):945-56. doi: 10.1007/s11259-009-9313-5.

PMID:
19685276
11.

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.

Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T.

Int J Antimicrob Agents. 2011 Mar;37(3):219-24. doi: 10.1016/j.ijantimicag.2010.10.029. Epub 2011 Jan 15.

PMID:
21239146
12.

Meticillin-resistant Staphylococcus aureus in pigs from Thailand.

Anukool U, O'Neill CE, Butr-Indr B, Hawkey PM, Gaze WH, Wellington EM.

Int J Antimicrob Agents. 2011 Jul;38(1):86-7. doi: 10.1016/j.ijantimicag.2011.02.018. Epub 2011 May 8. No abstract available.

PMID:
21550786
13.

Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.

Landman D, Kelly P, Bäcker M, Babu E, Shah N, Bratu S, Quale J.

J Antimicrob Chemother. 2011 Feb;66(2):332-4. doi: 10.1093/jac/dkq459. Epub 2010 Dec 3.

PMID:
21131322
14.

Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.

Lin G, Ednie LM, Appelbaum PC.

Antimicrob Agents Chemother. 2010 May;54(5):2258-61. doi: 10.1128/AAC.01350-09. Epub 2010 Feb 9.

15.

Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).

Mendes RE, Sader HS, Jones RN.

Int J Antimicrob Agents. 2010 Oct;36(4):374-9. doi: 10.1016/j.ijantimicag.2010.05.016. Epub 2010 Jul 3.

PMID:
20598860
16.

Prevalence of the genes encoding aminoglycoside-modifying enzymes and methicillin resistance among clinical isolates of Staphylococcus aureus in Tehran, Iran.

Yadegar A, Sattari M, Mozafari NA, Goudarzi GR.

Microb Drug Resist. 2009 Jun;15(2):109-13. doi: 10.1089/mdr.2009.0897.

PMID:
19496674
17.

Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Marks MI, Hammerberg S, Greenstone G, Silver B.

Antimicrob Agents Chemother. 1976 Sep;10(3):399-401.

18.

Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.

Tan CK, Lai CC, Liao CH, Lin SH, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2011 Jun;37(6):550-3. doi: 10.1016/j.ijantimicag.2011.01.018. Epub 2011 Apr 9.

PMID:
21482080
19.

[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M; Grupo VIRA..

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5. Spanish.

PMID:
19406529
20.

Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.

Ikeda-Dantsuji Y, Hanaki H, Sakai F, Tomono K, Takesue Y, Honda J, Nonomiya Y, Suwabe A, Nagura O, Yanagihara K, Mikamo H, Fukuchi K, Kaku M, Kohno S, Yanagisawa C, Nakae T, Yoshida K, Niki Y.

J Infect Chemother. 2011 Feb;17(1):45-51. doi: 10.1007/s10156-010-0085-1. Epub 2010 Jul 7.

PMID:
20607345

Supplemental Content

Support Center